From tuberculosis bedside to bench: ube2b splicing as a potential biomarker and its regulatory mechanism

HIGHLIGHTS

• who: Mengyuan Lyu from the The research flow of this work is summarized in Fig1a. Cohort recruitment The Clinical Trials and Biomedical Ethics Committee of West China Hospital, Sichuan University approved this study (Registration number of Chinese Clinical Trial Registry: ChiCTR1900028670). All participants provided informed consent. An in-house cohort, and an in-house cohort, were consecutively recruited. For the in-house cohort-1, participants were enrolled from West China Hospital of Sichuan University from January , to September, . TB patients in in-house cohort, need to meet the following criteria: (i) being diagnosed with TB according to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.